{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:07:55Z","timestamp":1787162875900,"version":"build-2736575974"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02084","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T02:13:25Z","timestamp":1598494405000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy"],"prefix":"10.3389","volume":"11","author":[{"given":"Cecilia Beatrice","family":"Chighizola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Adele","family":"Lonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Trespidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"J197","DOI":"10.1016\/j.jaut.2011.11.010","article-title":"Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome.","volume":"38","author":"Andreoli","year":"2012","journal-title":"J Autoimmun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.autrev.2014.12.011","article-title":"State of the art: reproduction and pregnancy in rheumatic diseases.","volume":"14","author":"Ostensen","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies.","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/ar3227","article-title":"Managing pregnancy in inflammatory rheumatological diseases.","volume":"13","author":"Jain","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome.","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity.","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses.","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/imr.12472","article-title":"The \u201cins and outs\u201d of complement-driven immune responses.","volume":"274","author":"Freeley","year":"2016","journal-title":"Immunol Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","article-title":"New insights into the immune functions of complement.","volume":"19","author":"Reis","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.4049\/jimmunol.173.11.6921","article-title":"Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex.","volume":"173","author":"Bossi","year":"2004","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood.v99.1.185","article-title":"Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo.","volume":"99","author":"Dobrina","year":"2002","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins.","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1073\/pnas.1311968111","article-title":"C1q as a unique player in angiogenesis with therapeutic implication in wound healing.","volume":"111","author":"Bossi","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination.","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.molimm.2011.04.011","article-title":"Complement activation in animal and human pregnancies as a model for immunological recognition.","volume":"48","author":"Girardi","year":"2011","journal-title":"Mol Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the complement system in normal pregnancy and preeclampsia.","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/aji.12586","article-title":"Complement component C1q as potential diagnostic but not predictive marker of preeclampsia.","volume":"76","author":"Agostinis","year":"2016","journal-title":"Am J Reprod Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.12659\/MSM.915777","article-title":"Serum levels of complement factors C1q, Bb, and H in normal pregnancy and severe Pre-Eclampsia.","volume":"25","author":"Jia","year":"2019","journal-title":"Med Sci Monit."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/eji.1830220635","article-title":"Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).","volume":"22","author":"Holmes","year":"1992","journal-title":"Eur J Immunol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4049\/jimmunol.151.3.1562","article-title":"Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins.","volume":"151","author":"Tedesco","year":"1993","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00055","article-title":"The complement system at the embryo implantation site: friend or foe?","volume":"3","author":"Bulla","year":"2012","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.molimm.2007.12.025","article-title":"Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.","volume":"45","author":"Bulla","year":"2008","journal-title":"Mol Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.4049\/jimmunol.0903215","article-title":"An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development.","volume":"185","author":"Agostinis","year":"2010","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00281-017-0645-x","article-title":"Complement activation, a threat to pregnancy.","volume":"40","author":"Girardi","year":"2018","journal-title":"Semin Immunopathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clim.2019.04.005","article-title":"Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss.","volume":"203","author":"Ohmura","year":"2019","journal-title":"Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1093\/humrep\/del229","article-title":"Complement as a predictor of further miscarriage in couples with recurrent miscarriages.","volume":"21","author":"Sugiura-Ogasawara","year":"2006","journal-title":"Hum Reprod."},{"key":"B28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1157\/13106775","article-title":"Hypocomplementemia in the absence of autoantibodies in women with recurrent pregnancy loss.","volume":"35","author":"Micheloud","year":"2007","journal-title":"Allergol Immunopathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/cei.12371","article-title":"Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta.","volume":"177","author":"Banadakoppa","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.","volume":"109","author":"Wikstrom","year":"2007","journal-title":"Obstet Gynecol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","article-title":"Role of complement component C1q in the onset of preeclampsia in mice.","volume":"58","author":"Singh","year":"2011","journal-title":"Hypertension."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement activation and regulation in preeclamptic placenta.","volume":"5","author":"Lokki","year":"2014","journal-title":"Front Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0897.2008.00631.x","article-title":"A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia.","volume":"60","author":"Than","year":"2008","journal-title":"Am J Reprod Immunol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/484321","article-title":"MBL interferes with endovascular trophoblast invasion in pre-eclampsia.","volume":"2012","author":"Agostinis","year":"2012","journal-title":"Clin Dev Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molimm.2019.06.015","article-title":"Interactions between the complement and endothelin systems in normal pregnancy and following placental ischemia.","volume":"114","author":"Regal","year":"2019","journal-title":"Mol Immunol."},{"key":"B36","first-page":"551","article-title":"Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.","volume":"73","author":"Haeger","year":"1989","journal-title":"Obstet Gynecol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jri.2012.11.006","article-title":"Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia.","volume":"97","author":"Denny","year":"2013","journal-title":"J Reprod Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy.","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1161\/HYPERTENSIONAHA.112.194324","article-title":"Preeclampsia is characterized by placental complement dysregulation.","volume":"60","author":"Buurma","year":"2012","journal-title":"Hypertension."},{"key":"B40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/10641955.2019.1640725","article-title":"Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.","volume":"38","author":"Yonekura Collier","year":"2019","journal-title":"Hypertens Pregnancy."},{"key":"B41","doi-asserted-by":"publisher","first-page":"354.e1","DOI":"10.1016\/j.ajog.2008.07.044","article-title":"Complement activation fragment Bb in early pregnancy and spontaneous preterm birth.","volume":"199","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/AOG.0b013e3181fc3afa","article-title":"Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.","volume":"117","author":"Lynch","year":"2011","journal-title":"Obstet Gynecol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.111.098475","article-title":"Complement C5A regulates prolabor mediators in human placenta.","volume":"86","author":"Lappas","year":"2012","journal-title":"Biol Reprod."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"beta(2) -Glycoprotein I: evolution, structure and function.","volume":"9","author":"de Groot","year":"2011","journal-title":"J Thromb Haemost."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100610","article-title":"The role of beta-2-glycoprotein I in health and disease associating structure with function: more than just APS.","volume":"39","author":"McDonnell","year":"2020","journal-title":"Blood Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In vivo distribution of beta2 glycoprotein I under various pathophysiologic conditions.","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.003","article-title":"The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.","volume":"90","author":"Chighizola","year":"2018","journal-title":"J Autoimmun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1177\/0961203319882507","article-title":"Complementemia in pregnancies with antiphospholipid syndrome.","volume":"28","author":"Tabacco","year":"2019","journal-title":"Lupus."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/rheumatology\/kes225","article-title":"Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?","volume":"51","author":"Reggia","year":"2012","journal-title":"Rheumatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0961203312444172","article-title":"Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.","volume":"21","author":"De Carolis","year":"2012","journal-title":"Lupus."},{"key":"B52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jri.2017.08.001","article-title":"Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: a multicenter study.","volume":"122","author":"Deguchi","year":"2017","journal-title":"J Reprod Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/annrheumdis-2017-212224","article-title":"Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and\/or antiphospholipid antibodies.","volume":"77","author":"Kim","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13185","article-title":"Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome.","volume":"82","author":"Scambi","year":"2019","journal-title":"Am J Reprod Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/path.2893","article-title":"Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.","volume":"225","author":"Cohen","year":"2011","journal-title":"J Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/1093526619836025","article-title":"Absence of distinct immunohistochemical distribution of annexin A5, C3b, C4d, and C5b-9 in placentas from patients with antiphospholipid antibodies, preeclampsia, and systemic lupus erythematosus.","volume":"22","author":"Matrai","year":"2019","journal-title":"Pediatr Dev Pathol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"167.e1","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01388","article-title":"Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications.","volume":"9","author":"Tedesco","year":"2018","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI18817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molimm.2004.07.043","article-title":"A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.","volume":"42","author":"Thurman","year":"2005","journal-title":"Mol Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","article-title":"TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss.","volume":"174","author":"Berman","year":"2005","journal-title":"J Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jri.2007.02.007","article-title":"Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation.","volume":"77","author":"Salmon","year":"2008","journal-title":"J Reprod Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1182\/blood-2015-09-672139","article-title":"Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery.","volume":"127","author":"Meroni","year":"2016","journal-title":"Blood."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006338","article-title":"Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: a case report.","volume":"96","author":"Gustavsen","year":"2017","journal-title":"Medicine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1182\/blood-2013-11-537704","article-title":"A non-complement-fixing antibody to beta2 glycoprotein I as a novel therapy for antiphospholipid syndrome.","volume":"123","author":"Agostinis","year":"2014","journal-title":"Blood."},{"key":"B67","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus.","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B68","first-page":"230","article-title":"IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.","volume":"18","author":"Siegert","year":"1991","journal-title":"J Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/0961203314547791","article-title":"Anti-C1q antibodies in systemic lupus erythematosus.","volume":"24","author":"Orbai","year":"2015","journal-title":"Lupus."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1084\/jem.154.6.1779","article-title":"Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis.","volume":"154","author":"Biesecker","year":"1981","journal-title":"J Exp Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/rheumatology\/kev307","article-title":"Eculizumab as rescue therapy in severe resistant lupus nephritis.","volume":"54","author":"Pickering","year":"2015","journal-title":"Rheumatology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00467-014-2944-y","article-title":"Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy.","volume":"30","author":"Coppo","year":"2015","journal-title":"Pediatr Nephrol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000431278","article-title":"Complement in lupus nephritis: new perspectives.","volume":"1","author":"Bao","year":"2015","journal-title":"Kidney Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"8563","DOI":"10.1073\/pnas.93.16.8563","article-title":"Amelioration of lupus-like autoimmune disease in NZB\/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.","volume":"93","author":"Wang","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B75","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nrrheum.2017.125","article-title":"The complement system as a potential therapeutic target in rheumatic disease.","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway.","volume":"7","author":"Macedo","year":"2016","journal-title":"Front Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/ard.45.5.359","article-title":"Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.","volume":"45","author":"Swaak","year":"1986","journal-title":"Ann Rheum Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1874312901711010113","article-title":"SLE and serum complement: causative, concomitant or coincidental?","volume":"11","author":"Sandhu","year":"2017","journal-title":"Open Rheumatol J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus.","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0961203311422093","article-title":"Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study.","volume":"21","author":"Batal","year":"2012","journal-title":"Lupus."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000056","article-title":"Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements.","volume":"1","author":"Putterman","year":"2014","journal-title":"Lupus Sci Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7326\/M19-0120","article-title":"Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States: a cross-sectional analysis.","volume":"171","author":"Mehta","year":"2019","journal-title":"Ann Intern Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/annrheumdis-2017-211641","article-title":"Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study.","volume":"77","author":"Skorpen","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2215\/CJN.11431116","article-title":"Kidney outcomes and risk factors for nephritis (Flare\/De Novo) in a multiethnic cohort of pregnant patients with lupus.","volume":"12","author":"Buyon","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0961203310388447","article-title":"Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese.","volume":"20","author":"Mok","year":"2011","journal-title":"Lupus."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/0961203310378669","article-title":"Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.","volume":"19","author":"Al Arfaj","year":"2010","journal-title":"Lupus."},{"key":"B87","doi-asserted-by":"publisher","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study.","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/annrheumdis-2012-202449","article-title":"Predictors of preterm birth in patients with mild systemic lupus erythematosus.","volume":"72","author":"Clowse","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0897.1992.tb00787.x","article-title":"Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy.","volume":"28","author":"Abramson","year":"1992","journal-title":"Am J Reprod Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/art.1780350109","article-title":"Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.","volume":"35","author":"Buyon","year":"1992","journal-title":"Arthritis Rheum."},{"key":"B91","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/pin.12041","article-title":"Complement split product C4d deposition in placenta in systemic lupus erythematosus and pregnancy-induced hypertension.","volume":"63","author":"Minamiguchi","year":"2013","journal-title":"Pathol Int."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00773","article-title":"Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome.","volume":"10","author":"Lonati","year":"2019","journal-title":"Front Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/pmj.77.905.157","article-title":"Pregnancy in systemic lupus erythematosus.","volume":"77","author":"Mok","year":"2001","journal-title":"Postgrad Med J."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02084\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T06:48:34Z","timestamp":1696574914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02084\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":94,"alternative-id":["10.3389\/fimmu.2020.02084"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02084","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"article-number":"2084"}}